UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
Rexahn Pharmaceuticals, Inc.
-------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $0.0001 per share
-------------------------------------------------------------------------------
(Title of Class of Securities)
761640 10 1
-------------------------------------------------------------------------------
(CUSIP Number)
Sung-Guan Choi
KT&G Corporation
100 Pyoungchon-dong Daedeok-gu
Taejon City, Korea 306-130
011-82-2-3404-4521
-------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
May 13, 2005
-------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
-------------------------------------------------------------------------------
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rules 13d-1(e), 13d-1(f) or 13d-1(g), check the following
box. |_|
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
----------------------
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 6 Pages
SCHEDULE 13D
---------------------- ----------------------
CUSIP No. 761640 10 1 Page 2 of 8 Pages
---------------------- ----------------------
------- ---------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
KT&G Corporation Not Applicable
------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_|
(b) |_|
------- ---------------------------------------------------------------------
3 SEC USE ONLY
------- ---------------------------------------------------------------------
4 SOURCE OF FUNDS
OO
------- ---------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) |_|
------- ---------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Republic of Korea
----------------- ------- ---------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 2,500,000
SHARES ------- ---------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
0
OWNED BY
------- ---------------------------------------------------
EACH
9 SOLE DISPOSITIVE POWER
REPORTING 2,500,000
PERSON ------- ---------------------------------------------------
WITH 10 SHARED DISPOSITIVE POWER
0
------- ---------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,500,000
------- ---------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES |_|
------- ---------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
6.0%
------- ---------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
CO
------- ---------------------------------------------------------------------
CUSIP NO. 761640 10 1 SCHEDULE 13D Page 3 of 8 Pages
Item 1. Security and Issuer.
-------------------
This statement relates to the common stock, par value $0.0001 per
share (the "Common Stock"), of Rexahn Pharmaceuticals, Inc., a Delaware
corporation (the "Issuer"). The Issuer's principal executive office is located
at 9620 Medical Center Drive, Rockville, MD 20850.
Item 2. Identity and Background.
-----------------------
The person filing this statement (the "Reporting Person"), the
executive officers and directors of the Reporting Person (the "Additional
Persons") and the information in respect of the Reporting Person and the
Additional Persons are as follows:
(a) The name of the Reporting Person is KT&G Corporation ("KT&G").
The names of the Additional Persons are set forth in Schedule A to this
statement which is incorporated herein by reference in its entirety.
(b) The principal business address of KT&G is 100 Pyoungchon-dong,
Daedeok-gu, Taejon City, Korea 306-130.
(c) The principal business of KT&G is the production and sale of
cigarettes, primarily in Asia. The business or residential address and present
principal occupation or employment (including the name and address of the
corporation or organization in which such employment is conducted) of each
Additional Person is set forth in Schedule A to this statement which is
incorporated herein by reference in its entirety.
(d) During the last five years, neither KT&G nor, to the knowledge
of KT&G, any of the Additional Persons has been convicted in a criminal
proceeding (excluding traffic violations or similar misdemeanors).
(e) During the last five years, neither KT&G nor, to the knowledge
of KT&G, any of the Additional Persons has been a party to a civil proceeding of
a judicial or administrative body of competent jurisdiction as a result of which
KT&G or any of the Additional persons was or is subject to a judgment, decree or
final order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or finding any violation
with respect to such laws.
(f) KT&G is a corporation organized under the laws of the Republic
of Korea. All of the Additional Persons are citizens of the Republic of Korea.
Item 3. Source and Amount of Funds or Other Consideration.
-------------------------------------------------
KT&G acquired 2,500,000 shares of Common Stock from the Issuer in
connection with the Merger described in Item 4.
CUSIP NO. 761640 10 1 SCHEDULE 13D Page 4 of 8 Pages
Item 4. Purpose of Transaction.
----------------------
The acquisition was made in connection with the Agreement and Plan
of Merger dated as of January 20, 2005 (the "Merger Agreement") by and among
Corporate Road Show.Com Inc., a New York corporation ("CPRD"), CRS Merger Sub,
Inc., a Delaware corporation and wholly owned subsidiary of CPRD ("Merger Sub"),
CRS Delaware, Inc., a Delaware corporation and wholly owned subsidiary of CPRD
("CRS Delaware"), and Rexahn, Corp, a Maryland corporation ("Rexahn"), pursuant
to which, immediately after giving effect to a 1-for-100 reverse stock split and
the reincorporation of CPRD as a Delaware corporation under the name "Rexahn
Pharmaceuticals, Inc.", Merger Sub merged with and into Rexahn, with Rexahn as
the surviving corporation (the "Surviving Company") and a wholly-owned
subsidiary of CPRD (the "Merger"). In the Merger, each share of Rexahn common
stock issued and outstanding prior to the Merger was converted into five shares
of Common Stock. Immediately prior to the Merger, KT&G held 500,000 shares of
Rexahn common stock. As a result of the Merger, KT&G received 2,500,000 shares
of Common Stock.
A copy of the Merger Agreement is incorporated herein by reference
as Exhibit 1.
Item 5. Interest in Securities of the Issuer.
------------------------------------
(a) As of the date hereof, KT&G beneficially owns 2,500,000 shares
of Common Stock, representing 6.0% of the outstanding shares of Common Stock.
This percentage is based upon the Issuer's statement as to the number of
outstanding shares of Common Stock as set forth in its Current Report on Form
8-K, filed with the Securities and Exchange Commission on May 16, 2005.
(b) The Board of Directors of KT&G has the sole power to vote or
to direct the vote, and dispose or direct the disposition, of all 2,500,000
shares of Common Stock KT&G acquired.
(c) Except for the acquisition reported herein, KT&G has not
effected any other transaction in the Common Stock within the past 60 days.
(d) No other person is known to have the right to receive or the
power to direct the receipt of dividends from, or the proceeds from the sale of,
the shares of Common Stock acquired by KT&G.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or
Relationships with Respect to Securities of the Issuer.
------------------------------------------------------
Not applicable.
CUSIP NO. 761640 10 1 SCHEDULE 13D Page 5 of 8 Pages
Item 7. Material to be Filed as Exhibits.
--------------------------------
Exhibit 1. Agreement and Plan of Merger, dated as of January 20, 2005,
by and among CPRD, Merger Sub, CRS Delaware and Rexahn is
incorporated by reference to Exhibit 2.1 to CPRD's Current
Report on Form 8-K filed on January 21, 2005.
Exhibit 2. Power of Attorney dated May 16, 2005.
CUSIP NO. 761640 10 1 SCHEDULE 13D Page 6 of 8 Pages
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and
belief, I hereby certify that the information set forth in this statement is
true, complete and correct.
Dated: May 23, 2005
KT&G Corporation
/s/ Ted T.H. Jeong
------------------------
Ted T.H. Jeong as Attorney-in-Fact
for KT&G
CUSIP NO. 761640 10 1 SCHEDULE 13D Page 7 of 8 Pages
SCHEDULE A
EXECUTIVE OFFICERS AND DIRECTORS OF KT&G CORPORATION
The following table sets forth the name, business address and present principal
occupation or employment of each executive officer and director of KT&G. Except
as otherwise indicated below, the business address of each person set forth on
this Schedule A is: c/o KT&G Corporation, 100 Pyoungchon-dong Daedeok-gu, Taejon
City, Korea 306-130.
------------------ -----------------------------------------------------------
NAME PRESENT PRINCIPAL OCCUPATION OR EMPLOYMENT
------------------ -----------------------------------------------------------
Young-Kyoon Kwak Chairman and Chief Executive Officer
------------------ -----------------------------------------------------------
Sung-Guan Choi Director
------------------ -----------------------------------------------------------
Kwang-Youl Lee Senior Managing Director of Marketing and Sales Headquarters
of KT&G
------------------ -----------------------------------------------------------
Young-Jin Min Senior Managing Director of Overseas Business Headquarters
of KT&G
------------------ -----------------------------------------------------------
Jin-Hyun Kim Senior Research Advisor
(Outside Director) Korea International Trade Association (Non-profit Business
Association)
102-901 Gaepo-Jai APT Gaepo-dong Gangnam-gu
Seoul, Korea 135-241 (Residence)
------------------ -----------------------------------------------------------
Yeon-Cheon Oh Professor
(Outside Director) Seoul National University (Educational institution)
San 56-1 Sillim-dong Gwanak-gu
Seoul, Korea 151-742 (Business)
------------------ -----------------------------------------------------------
Man-Woo Lee Professor
(Outside Director) Korea University (Educational institution)
Anam-dong Seongbuk-gu
Seoul, Korea 136-701 (Business)
------------------ -----------------------------------------------------------
Soon-Moo Soh Attorney
(Outside Director) Woo Yun Kang Jeong & Han (Law firm)
Textile Center 12F, 944-31 Daechi 3-dong Gangnam-gu, Seoul,
Korea 135-713 (Business)
------------------ -----------------------------------------------------------
Kyung-Jae Lee Professor
(Outside Director) Dongyang University (Educational institution)
1-1005 Hwarang APT Yoido-dong Yeongdeungpo-gu, Seoul, Korea
150-010 (Residence)
------------------ -----------------------------------------------------------
Byong-Kyun Kim Chief Executive Officer
(Outside Director) Daehan Investment and Securities (Investment Trust Company)
D-1001 Hanyang APT Yoido-dong Yeongdeungpo-gu, Seoul, Korea
150-010 (Residence)
CUSIP NO. 761640 10 1 SCHEDULE 13D Page 8 of 8 Pages
------------------ -----------------------------------------------------------
Sung-Gak Cha Director
(Outside Director) The National Council of YMCAs of Korea (Not-for-profit
community service organization)
698-8 1-dong Sangnock-gu, Ansan, Korea 426-160 (Residence)
------------------ -----------------------------------------------------------
Choong-Sup Kim President
(Outside Director) The Korea Research Institute of Chemical Technology
(Research institute)
P.O. Box 107 Yuseong-gu, Daejeon, Korea 305-600 (Business)
------------------ -----------------------------------------------------------
Ki-Ho Kim Executive Advisor
(Outside Director) STX Corporation (Holding company)
103-501 LG Hangang Jai APT Ichon-dong Yongsan-gu, Seoul,
Korea 140-030 (Residence)
------------------ ------------------------------------------------------------
Suck-Kyo Ahn Professor
(Outside Director) Hanyang University (Educational institute)
17 Haengdang-dong Seongdong-gu, Seoul, Korea 133-791
(Residence)
------------------ ------------------------------------------------------------